系统回顾术后恶心和呕吐的文献

Vilchis-Valentin David, García-Maldonado Merith, Larrazolo-Ochoa Arturo, Gutiérrez-Montes Laura Angélica, Camacho-Ramos Cesar Esteban, Norma Cuéllar-Garduño, R. López
{"title":"系统回顾术后恶心和呕吐的文献","authors":"Vilchis-Valentin David, García-Maldonado Merith, Larrazolo-Ochoa Arturo, Gutiérrez-Montes Laura Angélica, Camacho-Ramos Cesar Esteban, Norma Cuéllar-Garduño, R. López","doi":"10.15406/jaccoa.2023.15.00561","DOIUrl":null,"url":null,"abstract":"Introduction: Postoperative nausea and vomiting (PONV) is the most common adverse effect, after postoperative pain, with an incidence of 31.1% to 80%, which increases pain, favors broncho aspiration, wound dehiscence, and hematoma formation. Methodology: Systematized search keywords, postoperative nausea and vomiting, Incidence, therapeutics, Apfel score and risk score for postoperative nausea and vomiting, in PubMed database, the Cochrane central register of controlled trials and in http://www.clinicaltrials.gov. Results: A total of 2750 articles were obtained, and 62 articles were chosen for inclusion. Discussion: The drugs used as monotherapy to mitigate PONV such as palonosetron, fosaprepitant and aprepitant, show better results than the rest of the drugs. Conclusion: Currently, NK1 receptor antagonist drugs and 5-HT3 antagonists have been shown to have the best results in preventing PONV, however, the management of PONV should be multimodal and individualized.","PeriodicalId":228896,"journal":{"name":"Journal of Anesthesia and Critical Care: Open access","volume":"15 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Systematized review of the literature on postoperative nausea and vomiting\",\"authors\":\"Vilchis-Valentin David, García-Maldonado Merith, Larrazolo-Ochoa Arturo, Gutiérrez-Montes Laura Angélica, Camacho-Ramos Cesar Esteban, Norma Cuéllar-Garduño, R. López\",\"doi\":\"10.15406/jaccoa.2023.15.00561\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Postoperative nausea and vomiting (PONV) is the most common adverse effect, after postoperative pain, with an incidence of 31.1% to 80%, which increases pain, favors broncho aspiration, wound dehiscence, and hematoma formation. Methodology: Systematized search keywords, postoperative nausea and vomiting, Incidence, therapeutics, Apfel score and risk score for postoperative nausea and vomiting, in PubMed database, the Cochrane central register of controlled trials and in http://www.clinicaltrials.gov. Results: A total of 2750 articles were obtained, and 62 articles were chosen for inclusion. Discussion: The drugs used as monotherapy to mitigate PONV such as palonosetron, fosaprepitant and aprepitant, show better results than the rest of the drugs. Conclusion: Currently, NK1 receptor antagonist drugs and 5-HT3 antagonists have been shown to have the best results in preventing PONV, however, the management of PONV should be multimodal and individualized.\",\"PeriodicalId\":228896,\"journal\":{\"name\":\"Journal of Anesthesia and Critical Care: Open access\",\"volume\":\"15 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Anesthesia and Critical Care: Open access\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15406/jaccoa.2023.15.00561\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Anesthesia and Critical Care: Open access","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/jaccoa.2023.15.00561","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

简介:术后恶心呕吐(PONV)是术后疼痛后最常见的不良反应,发生率为31.1% ~ 80%,加重疼痛,易发生支气管吸痰、伤口裂开、血肿形成。方法:系统化搜索关键词,术后恶心呕吐,发生率,治疗方法,术后恶心呕吐的Apfel评分和风险评分,检索PubMed数据库,Cochrane对照试验中心注册库和http://www.clinicaltrials.gov。结果:共纳入文献2750篇,入选文献62篇。讨论:帕洛诺司琼、磷沙匹坦、阿瑞匹坦等单药缓解PONV的效果优于其他药物。结论:目前,NK1受体拮抗剂和5-HT3拮抗剂对PONV的预防效果最好,但PONV的治疗应多模式、个体化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Systematized review of the literature on postoperative nausea and vomiting
Introduction: Postoperative nausea and vomiting (PONV) is the most common adverse effect, after postoperative pain, with an incidence of 31.1% to 80%, which increases pain, favors broncho aspiration, wound dehiscence, and hematoma formation. Methodology: Systematized search keywords, postoperative nausea and vomiting, Incidence, therapeutics, Apfel score and risk score for postoperative nausea and vomiting, in PubMed database, the Cochrane central register of controlled trials and in http://www.clinicaltrials.gov. Results: A total of 2750 articles were obtained, and 62 articles were chosen for inclusion. Discussion: The drugs used as monotherapy to mitigate PONV such as palonosetron, fosaprepitant and aprepitant, show better results than the rest of the drugs. Conclusion: Currently, NK1 receptor antagonist drugs and 5-HT3 antagonists have been shown to have the best results in preventing PONV, however, the management of PONV should be multimodal and individualized.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信